Ojjaara (momelotinib)

KEE Patient Case Outline

Step 1 of 250%

About you

So we know whose case this is and can follow up if we have questions.

Your answers are saved on this device as you go.

©2026 GSK group of companies or its licensor.

Trade marks are owned by or licensed to the GSK group of companies.

GSK